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Developmental constraint
through negative pleiotropy in the zygomatic
arch
Christopher J. Percival1* , Rebecca Green2,3,4, Charles C. Roseman5, Daniel M. Gatti6, Judith L. Morgan6,
Stephen A. Murray6, Leah Rae Donahue6, Jessica M. Mayeux7, K. Michael Pollard7, Kunjie Hua8, Daniel Pomp8,
Ralph Marcucio9 and Benedikt Hallgrímsson2,3,4*

Abstract
Background: Previous analysis suggested that the relative contribution of individual bones to regional skull lengths
differ between inbred mouse strains. If the negative correlation of adjacent bone lengths is associated with genetic
variation in a heterogeneous population, it would be an example of negative pleiotropy, which occurs when a
genetic factor leads to opposite effects in two phenotypes. Confirming negative pleiotropy and determining its basis
may reveal important information about the maintenance of overall skull integration and developmental constraint
on skull morphology.
Results: We identified negative correlations between the lengths of the frontal and parietal bones in the midline
cranial vault as well as the zygomatic bone and zygomatic process of the maxilla, which contribute to the zygomatic
arch. Through gene association mapping of a large heterogeneous population of Diversity Outbred (DO) mice, we
identified a quantitative trait locus on chromosome 17 driving the antagonistic contribution of these two zygomatic
arch bones to total zygomatic arch length. Candidate genes in this region were identified and real-time PCR of the
maxillary processes of DO founder strain embryos indicated differences in the RNA expression levels for two of the
candidate genes, Camkmt and Six2.
Conclusions: A genomic region underlying negative pleiotropy of two zygomatic arch bones was identified, which
provides a mechanism for antagonism in component bone lengths while constraining overall zygomatic arch length.
This type of mechanism may have led to variation in the contribution of individual bones to the zygomatic arch noted
across mammals. Given that similar genetic and developmental mechanisms may underlie negative correlations in
other parts of the skull, these results provide an important step toward understanding the developmental basis of
evolutionary variation and constraint in skull morphology.
Keywords: Craniofacial, Skull, Micro-computed tomography, Morphometrics, Integration, QTL analysis, Diversity
Outbred, RT-PCR, Mus musculus
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Background
The skull is a complex structure that supports and protects tissues critical for survival, including the brain,
sense organs, and masticatory apparatus. While a wide
range of skull morphology has evolved across mammalian species, fundamental patterns of skull bone
integration are generally conserved [1–4]. This shared
morphological pattern reflects conserved tissue origins
[5], ossification patterns [6–8], and strong selective pressure for an adequately integrated and functional head
[2, 9]. The same factors that reinforce the development
of an integrated head can serve as developmental constraints on the directions that evolution can take [10, 11].
Understanding the genetic basis for this integration and
developmental constraint is critical for illuminating how
genes and development can influence processes of evolution. Here, we investigate the genetic basis for negative correlations between adjacent skull bones in a large
genetically heterogeneous population of mice. These
negative correlations may serve as developmental constraints that support overall integration of the head while
also allowing for significant variation in the relative size
of individual bones within subregions. Identifying genetic
factors underlying this type of developmental constraint
is important for understanding the basis of morphological integration and will illuminate critical connections
between developmental and evolutionary processes.
Random pairs of linear distances across the skull are
expected to display positive correlations driven by the
overall growth of the integrated head. Negative correlations between raw linear distance measurements are rare
and can be evidence of scale-independent negative pleiotropy, which exists when genetic variation leads to an
opposite phenotypic effect on two traits [10, 12]. Within
the craniofacial skeleton, a pair of negatively correlated
and adjacent bone lengths provides a relatively simple
system within which to search for genes underlying negative pleiotropy. Although not as commonly discussed,
negative pleiotropy is fundamentally different than antagonistic pleiotropy, which occurs when a genetic factor
contributes a positive fitness effect for at least one trait
and a negative fitness effect for at least one other trait
[13–15]. The concept of negative pleiotropy does not
require either trait to be associated with a fitness effect.
However, the existence of negative pleiotropy itself might
have either positive or negative fitness effects, depending
on the evolutionary context.
A previous analysis of adult skull variation indicated
that linear dimensions of the cranial vault, zygomatic
arch, and cranial base vary strongly among the eight
inbred mouse founder strains of the Collaborative Cross
(CC). Furthermore, that analysis indicated that pairs
of bones within each of these regions display negative
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correlations in relative size [16]. Here, we explicitly tested
whether pairs of adjacent linear distances within cranial
vault, zygomatic arch, and cranial base are negatively correlated. In cases where they were, we performed genomewide mapping in a large heterogeneous population of
Diversity Outbred (DO) mice to identify genomic regions
driving negative pleiotropy. The DO mice are derived
from the CC founder strains. Each mouse carries a high
degree of heterozygosity and a unique combination of
alleles [17, 18], which is ideal for high-resolution genetic
mapping. Although genome-wide mapping has been performed on DO mice for other phenotypes such as blood
measurements and body composition [17–19], this is the
first study that addresses craniofacial morphology.
Previous quantitative trait locus (QTL) analyses of
mouse craniofacial variation have illustrated the ubiquity
of pleiotropy in the genetics of craniofacial form [20–22]
and identified candidate genes associated with variation
in multivariate measures of craniofacial shape in a variety of mouse populations [23–27], including another outbred mouse sample [28]. The DO mice may prove more
valuable than previously analyzed mouse crosses or backcrosses, because they represent a strongly genetically heterogeneous population that has been outbred for more
than 10 generations, leading to relatively high genomic
mapping resolution. In addition, haplotype variation at
a given SNP can be tied back to the complete genomic
sequence of eight diverse inbred founder strains.
Within our mapping results, we expect that a locus
driving negative pleiotropy will have a significant haplotype effect on the linear distances of each adjacent bone.
Furthermore, we expect that variation in founder strain
haplotypes at this locus will be associated with opposite phenotypic effects for each bone (i.e., one bone gets
longer when the other gets shorter). Third, if this locus
represents a developmental constraint on the morphology of the combined length of both bones, we expect that
local haplotype variation will have no effect on overall
regional length. Identifying a genomic region associated
with negative pleiotropy and candidate genes within it is
a critical first step in understanding an important genetic
and developmental basis for both developmental constraint and variation in the relative contribution of bones
to regional skull morphology. Although our analyses are
regionally specific, identifying the general mechanisms
underlying negative pleiotropy of adjacent skeletal elements is an important step toward understanding the
developmental basis for evolutionary change in the skull.

Methods
Adult and embryonic sample

Our measurements of the Collaborative Cross (CC)
founder strains and their F1 crosses derive from

Percival et al. EvoDevo (2018) 9:3

craniofacial landmarks collected from 1211 specimens
for a previous analysis [16]. The Diversity Outbred (DO)
mice are the result of multiple generations of random
outcrossing of 175 breeding pairs from partially inbred
CC lines [18] at the Jackson Laboratory (JAX; Bar Harbor, ME). Our primary sample consisted of mice raised at
the University of North Carolina (UNC), and at JAX. The
287 adult specimens raised at UNC were male and female
sibling pairs from outbreeding generation 10 that were
raised in previously described conditions [19, 29] under
approval and conduced in accordance with the guidelines
set forth by the Institutional Animal Care and Use Committee (IACUC) at the University of North Carolina at
Chapel Hill. The 277 adult specimens raised at Jackson
Labs (JAX IACUC #99066) were females of outbreeding
generations 9, 10, and 15.
A sample of 472 DO mice of generations 19, 21, and
23, raised at the Scripps Research Institute (IACUC #080150-3), were used to validate relevant QTLs identified
by genome-wide association in our primary sample. This
validation sample was chosen because it includes mice
from later DO generations with greater recombination,
which might allow for the refinement of any validated
QTL (i.e., shorter confidence intervals). After collection, adult specimens were stored at −20 °C. Receipt and
imaging of specimens from other institutions was conducted in accordance with approved IACUC protocol
#AC13-0268 at the University of Calgary.
Embryonic specimens from A/WySnJ (AWS), C57BL/6J
(C57), and WSB/EiJ (WSB) inbred backgrounds were collected at the University of Calgary at embryonic day (E)
11.5 and processed as recently described [30]. Briefly,
embryos were fixed overnight in PaxGene tissue fix solution (Qiagen, PreAnalytics, cat #765312) then stored at
−20 °C in the PaxGene tissue stabilizer solution prepared
to manufacturer specification (Qiagen, PreAnalytics, cat
#765512). Embryonic collection and processing were
conducted in accordance with approved IACUC protocol
AC13-0267 at the University of Calgary.
Linear distances versus relative linear dimensions

Negative relationships between the length of bones making up the zygomatic arch, sagittal cranial vault, and
posterior cranial base were previously identified among
the eight CC founder strains from plots of relative linear
dimensions that differ strongly between a given founder
strain and several of the other founder strains [16]. Unlike
standard linear distances, these relative dimensions were
calculated from landmark coordinates after they were
scaled to remove overall size variation and then transformed to remove the linear component of static allometry. These steps were necessary in the previous analysis of
craniofacial shape between genotypes with a wide range
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of sizes, including small wild-derived strains and the
very large New-Zealand Obese strain. However, because
most raw linear distances are positively correlated with
head size, removing variation that covaries with overall
size can create artefactual negative associations between
many of the resulting linear dimensions. For instance,
two randomly selected linear distances are both strongly
positively correlated with head size (centroid size)
(Fig. 1a, b). They are also strongly positively correlated
with each other (Fig. 1c). After scaling landmark coordinates underlying these measurements by overall skull
size during Procrustes superimposition, variation that
is correlated with overall scale is removed, regardless of
whether that variation is mechanistically or developmentally related to overall size variation. This frequently leads
to an artificial negative correlation between the resulting
linear dimensions (Fig. 1d). Correlation coefficients from
many linear distance pairs illustrates how scaling during
Procrustes superimposition changes an asymmetric distribution of correlation coefficients between raw linear
distances into a symmetric distribution of correlation
coefficients centered on zero (Fig. 1e). Because this scaling procedure magnifies aspects of negative covariation,
we completed our current analysis of potential developmental constraints on adjacent bones using raw linear
distances to make certain that our evidence for negative
relationships between these skull lengths are genuine.
Phenotype measurement

Micro-computed tomography (µCT) images of heads
were obtained in the 3D Morphometrics Centre at the
University of Calgary with a Scanco vivaCT40 scanner
(Scanco Medical, Brüttisellen, Switzerland) at 0.035 mm
voxel dimensions at 55 kV and 145 µA. Three dimensional coordinates of 54 adult landmarks (8 midline, 46
bilateral), as previously defined [16], were collected by a
single observer from minimum threshold defined bone
surfaces within Analyze 3D (www.mayo.edu/bir/).
We calculated linear distances associated with zygomatic arch length, sagittal cranial vault length, and midline cranial base length from raw landmark coordinates
collected on both CC founder/F1 specimens and DO
specimens (Fig. 2). Full zygomatic arch length was calculated as the linear distance between landmarks L(R)3
and L(R)32, with the length of zygomatic process of the
maxilla defined between L(R)3 and L(R)24 and zygomatic bone length defined between L(R)24 and L(R)32.
Full cranial vault length was defined between M21 and
M27, while the length of the frontal and parietal bones
were defined between M21–M26 and M26–M27, respectively. Posterior cranial base length was defined between
M36 and M38, while the lengths of the basioccipital and
sphenoid bones were defined between M36–M37 and
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Fig. 1 Linear distance correlations and scaling. Plots of two randomly chosen linear distances calculated from our CC founder and F1 sample
illustrating the change in correlation direction after scaling measures to overall skull size (centroid size). Plots of raw linear distance a L15–R22 and
b R32–R2 versus skull centroid size. Plots of linear distance L15–R22 versus R32-R2 c before and d after Procrustes superimposition-based scaling
(based on centroid size). e Correlation coefficients from 10,000 randomly permuted linear distance pairs calculated from raw linear distances (left)
and after (right) Procrustes superimposition and scaling

M37–M38, respectively. We completed our analysis of
the zygomatic arch lengths on the average of the left and
right sides to help control for any stochastic landmarking error or stochastic developmental variation between
the left and right sides. We were unable to do this for the
other measurements, because they are found along the
midline of the skull.
The Pearson’s correlation coefficient (r) for each pair
of component linear distances (e.g., zygomatic bone
length vs. zygomatic process of maxilla length) and
between each component linear distance and the overall
trait length (e.g., zygomatic bone length vs. total zygomatic arch length) was calculated to identify correlation
direction and strength. A t test of whether the r is different from 0 was completed for each pair to determine
whether their correlation is significant, after Bonferroni
correction to account for multiple testing (α = 0.0028).
The coefficient of determination (R2) is interpreted as a
measure of how much variance in one length in a pair is
explained by the other.
Genotyping and association mapping

Tail biopsies were taken from mice at 6 weeks of age, and
DNA was either extracted from the tissue using the QIAGEN DNeasy kit per manufacturer’s instructions or sent
to NeoGen GeneSeek for DNA extraction. The primary

DO sample was genotyped using the MegaMUGA SNP
array [GeenSeek (Neogen), Lincoln, NE] [31], while the
validation sample was genotyped using the GigaMUGA
array (GeenSeek (Neogen), Lincoln, NE) [32]. We used
a subset of 57,977 MegaMUGA SNPs or 120,789 GigaMUGA SNPs that distinguish among the genotypes of
the eight CC founder strains and their heterozygous F1
offspring and have a quality tier of 1 or 2 [32]. The probability that each of the eight founder strains contributed to
a given SNP maker was calculated for each DO specimen
based on array intensity values using the DOQTL package [17] within R [33].
Association mapping was performed using DOQTL
[17] for both components and the overall trait length of
linear distance pairs that displayed a significant negative relationship within our primary DO mouse sample.
First, we completed genome scans for the primary sample using an additive haplotype model for regression of
the specimen founder genotype dosage on an individual
linear distance, with age at sacrifice and sex as covariates.
Peaks indicating regions of the genome where haplotype
covaries with a given trait were identified as those with
LOD scores above a genome-wide significance threshold
determined with permutation tests (1000 iterations, indicating a LOD score ~ 7.76). The support intervals under
these significant peaks were identified as continuous
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Fig. 2 Linear distances for analysis. Pairs of linear distances that
were tested for a negative correlation within CC founder/F1 and DO
samples, plotted between previously defined craniofacial landmarks
[16]. a Sagittal cranial vault lengths of the frontal bone (red) and parietal bone (blue) plotted on a superior view, b posterior cranial base
lengths of the basioccipital (blue) and sphenoid body (red plotted
on an interior view, c zygomatic arch lengths of the zygomatic bone
(blue) and zygomatic process of the maxilla (red) on a lateral view

regions including 2 LOD scores below the LOD score
value of that significant peak. The results of these additive
haplotype regressions also indicate which founder haplotypes are associated with positive or negative increases in
linear distance length. We completed association mapping using an additive SNP-based regression model [17]
across the genomic intervals of interest that were identified in the previous step. A permutation test of the SNPbased regression model across the genome was used to
determine the LOD score significance threshold for these
tests. Second, to validate significant peaks on chromosome 17, we completed the same association mapping
steps with our validation sample for zygomatic arch distances across chromosome 17 (rather than across the
whole genome).

The E11.5 maxillary process was chosen for RT-PCR
because both the maxilla and zygomatic bones are
derived from mesenchymal condensations within this
process (see “Discussion”), starting at approximately
E11.5. Specifically, this age was chosen because it is the
approximate time when morphogenesis and differentiation of the facial skeleton begins [34, 35]. Mouse embryos
were dissected in ice cold PBS and immediately preserved
using the PaxGene tissue system (Qiagen, PreAnalytics cat #765312, 765512). Embryos were fixed overnight
in the fix at room temperature with rocking, then transferred to the stabilization buffer and stored at −20 °C.
Maxillary processes were subsequently micro-dissected
from five A/WySnJ (AWS), five C57BL/6J (C57), and six
WSB/EiJ (WSB) embryos that had been stored in PaxGene tissue stabilization buffer and were stored in fresh
stabilization buffer at −20 °C until extraction. AWS
embryos were used in place of A/J embryos, because they
were available at the University of Calgary and because
the two are closely related inbred strains.
Following a recently published analysis [30], RNA was
extracted using the PaxGene RNA extraction kit (Qiagen, PreAnalytics cat #766134), which includes a DNA
removal step. RNA was analyzed using a NanoDrop
1000 (ThermoFisher). While RIN analysis was not performed on these samples, a similar group of samples
processed during the same time span (Agilent BioAnalyzer) had RIN scores in the area of 7.9–8.3, which is
in line with kit specifications. 500 ng of RNA was converted to cDNA using the Maxima First Strand Kit (ThermoFisher, Cat #K1641) in a 25 µl reaction. Real-time
PCR was performed on an Applied Biosystems Quantiflex Studio 6 using standard cycling conditions with the
low volume (10 µl) setting. Reactions were performed
using the 2× PrimeTime gene expression mastermix
from Integrated DNA Technologies with low ROX,
PrimeTime assays (Gapdh—Mm.PT.39a.1, Camkmt—
Mm.PT.58.7890215,
Six3os1—Mm.PT.58.43925739,
Six2—Mm.PT.58.22007192), an ABI Taqman assay
(18s—Mm0477571_s1), and custom Six3 primers (Probe:
5′-C AAAC TTCG CCGATTC TC ACC AC TG C T-3′,
Forward primer: 5′-TCTCTATTCCTCCCACTTCTT
GTTG-3′, Reverse primer: 5′-GCCGCTACTCGCCA
GAAGTA-3′) [36]. Additional primer sequence details
are found in Additional file 1. Normalization was done
using the arithmetic average of the deltaCT from Gapdh
and 18 s RNA runs. Reference genes were selected based
on stability from previous experiments and RNAseq data
from this region of the face.
Since C57 mice had an intermediate phenotypic effect,
mean C57 RNA expression was used as the baseline
upon which to compare the expression of all specimens
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(measured as fold change). One-way ANOVA tests of
fold-change values between genotypes were completed
for Camkmt, Six2, Six3, and Six3OS1 using Graphpad
Prisim (Version 6) software. If there were differences in
expression between genotypes, we looked for similarities
between variation in RNA expression and the phenotypic
effects of A-strain, C57, and WSB haplotypes on relative
zygomatic bone length, which might indicate that variation in expression of these candidate genes is associated
with the identified negative correlation in zygomatic
bone lengths. This was done by using a post-test for linear trend.

Results
We explicitly tested whether the lengths of adjacent
bones within the cranial base, cranial vault, and zygomatic arch were negatively correlated. While we expected
that most linear distances in the skull would be positively correlated, a negative correlation is evidence for a
developmental constraint in how component bones (e.g.,
frontal and parietal bones) contribute to a larger overall trait (e.g., cranial vault length). All component bone
lengths were significantly positively correlated with corresponding overall trait lengths (Table 1). The lengths of
component bones of the zygomatic arch were negatively
correlated within the CC Founder/F1 and DO samples,
while cranial vault components were negatively correlated within the DO sample. There was no evidence of a
negative association between components of the posterior cranial base.
Association mapping

Given the negative correlations between the length
of bones contributing to the zygomatic arch and cranial vault, we completed genome-wide association

mapping to look for evidence of a genomic region that
might drive these correlations based on the mechanism of negative pleiotropy. Our association mapping
analysis revealed two intervals on chromosome 17 that
were associated with zygomatic bone length variation
(42.04829–45.95447; 85.30648–85.88324 Mb), while the
second of these intervals (85.30648–85.88324 Mb) was
also associated with zygomatic process of the maxilla
length variation (Fig. 3b, c). The phenotypic effects of
founder haplotypes under the second peak were in opposite directions for the two components (Fig. 4), meaning
that a founder haplotype associated with an increase in
zygomatic length was also associated with a decrease
in zygomatic process of the maxilla length. This closely
matches our expectation for a gene underlying negative
pleiotropy between two components of a larger trait. Furthermore, this interval displays a significant LOD score
for both components but not for total zygomatic arch
length (Fig. 3a), which meets our expectation that a gene
underlying a developmental constraint on zygomatic
arch morphology will have opposite effects on the relative contribution of the components to zygomatic arch
length without effecting overall arch length. Chromosome specific association mapping with our validation
sample confirmed the second zygomatic peak on chromosome 17 (84.37429–85.86122 for zygomatic bone;
83.71674–85.88897 for zygomatic process of maxilla),
the general phenotypic effects of haplotypes under this
peak (Additional file 2), and suggested a few other significant peaks on chromosome 17 related to zygomatic
arch length (Fig. 5). In addition, a single significant peak
on the X chromosome was noted for total cranial vault
length (98.220635–100.409455) in our primary sample,
but it did not reach significance in our validation sample.
This vault length peak was not further pursued in this

Table 1 Linear distance correlations
Linear distance 1

Linear distance 2

CC founder/F1

DO

Pearson’s
R
correlation
coefficient (r)

2

R2
r ≠ 0 t test Pearson’s
correlation
p value
coefficient (r)

− 0.232

0.054

< 0.001

0.465

0.216

< 0.001

0.748

0.560

− 0.034

0.776

Vault Length (M21–M27)

Basioccipital (M36–M37)
Basioccipital (M36–M37)
Sphenoid Body (M37–M38)

Zygomatic Process of Maxilla (L3–L24)

Zygomatic Bone (L24–L32)

Zygomatic Process of Maxilla (L3–L24)

Full Zygomatic Arch (L3–L32)

Zygomatic Bone (L24–L32)

Full Zygomatic Arch (L3–L32)

Frontal Bone (M21–M26)

Parietal Bone (M26–M27)

Frontal Bone (M21–M26)

Vault Length (M21–M27)

Parietal Bone (M26–M27)

− 0.294

r ≠ 0 t test
p value

0.086 < 0.001

0.620

0.385

< 0.001

< 0.001

0.561

0.315

< 0.001

0.001

0.232

0.602

< 0.001

− 0.345

0.603

0.363

Sphenoid Body (M37–M38)

0.592

Posterior Cranial Base (M36–M38)

0.870

Posterior Cranial Base (M36–M38)

0.912

0.119 < 0.001

0.622

0.386

< 0.001

< 0.001

0.519

0.270

< 0.001

0.350

< 0.001

0.333

0.111

< 0.001

0.757

< 0.001

0.786

0.618

< 0.001

0.832

< 0.001

0.844

0.713

< 0.001

Bolditalic indicates a significant negative correlation after accounting for multiple testing with Bonferonni correction (α = 0.0028)
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Fig. 3 Genome-wide scan results. The results of genome-wide scan using an additive haplotype model to identify genomic regions significantly
associated with a full zygomatic arch length (landmark 3–33), b zygomatic process of the maxilla length (landmark 3–24), and c zygomatic bone
length (landmark 24–33). The red line is a permutation-based (1000 iterations) significant LOD score of 7.76

study because it did not reach significance for either cranial vault component.
Association mapping across the support interval of
the second peak associated with zygomatic arch variation on chromosome 17 (85.30648–85.88324 Mb)
indicates there are 19 known or predicted genes in this
region (Fig. 6). These include three protein-coding genes
(Six2, Six3, Camkmt) and one well-studied non-coding
RNA (Six3os1). We noted that the WSB and A/J founder

haplotypes are associated with opposite phenotypic
effects for zygomatic bone and zygomatic process of the
maxilla lengths, while the C57 haplotype effect is intermediate (Fig. 4). Therefore, if differences in the expression level of a protein-coding gene were responsible for
founder haplotype associated variation in zygomatic
bone length, we expected that A-strain and WSB expression levels would be most different, while C57 expression
would be intermediate.
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Phenotypic coefficients are the effect of having a certain founder strain genotype at a specific genomic location on a measurement

RT‑PCR

To test whether the expression of these four candidate
genes met this expectation, we collected maxillary
prominences from embryonic day (E) 11.5 embryos
of AWS, C57, and WSB mice, which had been stage
matched by tail somite number. We then completed
RT-PCR on these tissue samples using three replicates
for each sample to quantify RNA expression levels
for Camkmt, Six2, Six3, and Six3os1. All fold-change
values were compared to the C57 mean as a baseline.
One-way ANOVA results indicate genotype identity
significantly contributes to Camkmt and Six2 RNA
expression (Table 2). In both cases, a post-test for linear trends is significant when genotypes are ordered
as WSB, C57, then AWS. WSB displays relatively high
mean Camkmt RNA expression levels and relatively
low Six2 levels. AWS displays relatively high mean
Six2 levels and intermediate mean Camkmt levels

(Fig. 7). No significant trends are noted for either Six3
or Six3OS1.

Discussion
Within a sample of DO mice, we confirmed negative correlations between the lengths of bones contributing to
the cranial vault and found strong evidence for negative
pleiotropy between the length of the zygomatic bone and
the zygomatic process of the maxilla. A genomic interval
on chromosome 17 (85.3–85.9 Mb) met all our expectations for a genetic basis of negative correlation between
these adjacent zygomatic arch bones. Specifically, there
were significant and opposite haplotype effects on zygomatic and zygomatic process length (Figs. 3a, b, and 4),
but no significant haplotype association with overall
zygomatic arch length (Fig. 3c). This example of negative
pleiotropy shows how skull shape can be conserved while
the individual bone contributions to that shape can vary.
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5
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Fig. 5 Validation sample chromosome 17 scan results. The results
of chromosome 17 specific scan using an additive haplotype model
to identify genomic regions significantly associated with a full
zygomatic arch length (landmark 3–33), b zygomatic process of the
maxilla length (landmark 3–24), and c zygomatic bone length (landmark 24–33). The red line is a permutation-based (1000 iterations)
significant LOD score of 5.75

The development of an integrated skull that fits together
well enough for masticatory, sense organ, breathing, and
brain function is necessary for survival [1, 11, 12, 37]. Just
as with any skull region, the range of possible zygomatic
arch phenotypes that allow for proper skull integration
and function is limited. Our results illustrated a mechanism of developmental constraint that supports skull
integration while allowing for variation in how specific
bones contribute to a fundamentally conserved mammalian skull morphology.
Phenotypic impact of candidate region variation

There is a significant association between haplotype variation under a genomic region on mouse chromosome 17
and variation in the lengths of the zygomatic process of
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the maxilla and the zygomatic bone. While we are confident that there is a causal factor in this region, zygomatic arch element lengths are likely highly polygenic as
is the norm for skull morphology [22, 38]. As with most
skull bone lengths, the length of the zygomatic bone and
the zygomatic process of the maxilla also correlate positively with skull size. In fact, the amount of variation
explained by the correlation with skull size (as measured
by R2) is greater than the amount of variation explained
by the negative correlation between the two zygomatic
components (Table 1). Additionally, the greatest difference between haplotype specific phenotypic effects in
our genomic interval is about 0.4 mm (Fig. 4), which is
approximately one standard deviation for these bone
length measurements across our DO mice. Although the
identified negative pleiotropy plays an important role in
limiting overall zygomatic arch morphology, system-wide
growth factors play a stronger role in determining all
zygomatic arch bone lengths.
In addition to the interval displaying negative pleiotropy, another peak on chromosome 17 between 42 and
46 Mb met the genome-wide significance level for association with zygomatic bone length. With larger samples
and different measurements of zygomatic arch morphology, other regions of interest would also be identified (as
in [39]). Furthermore, although a mouse with the WSB
haplotype under our interval of interest had, on average,
a 0.3 mm shorter zygomatic bone than other DO mice
(Fig. 4), WSB inbred founder mice don’t all have a shorter
zygomatic bone than other inbred founder strains. This
is because WSB alleles in other regions of the genome
also contribute to the total WSB founder strain phenotype. Variation in even small-scale skull morphologies is
produced by the combination of numerous factors, some
acting globally across an organism and some acting more
locally [11, 22]. However, determining the genetic factor
on mouse chromosome 17 that drives negative pleiotropy
within the zygomatic arch may help to reveal an important basis of developmental constraint and evolutionary
change within the skull.
Candidate genes

Three protein-coding genes (Camkmt, Six3, and
Six2) and one non-coding RNA with known function
(Six3os1) are found under our candidate region of interest (Fig. 6). Our real-time PCR results indirectly support Camkmt and Six2 as candidate genes. Although
we cannot definitively rule out other genetic factors
under and near this genomic interval as candidates, we
speculate that changes in the expression of at least one
of these four identified factors might be responsible for
the noted negative pleiotropy in zygomatic arch element
length.
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Fig. 6 Association mapping results. Results of association mapping under the significant peak that is found in the genome-wide scan results for
both zygomatic bone length and zygomatic process of maxilla length

Table 2 ANOVA post-test for a linear trend in RNA expression, where the alternate hypothesis is that the level
of expression is ordered by genotype with C57 being intermediate to the other two genotypes (AWS and WSB)
Gene

Slope

Camkmt

− 0.2118

Six2
Six3
Six3OS1

0.2949

R2

p value

0.5009

0.0014**

0.3342

0.0237*

0.1141

0.04933

0.426

− 0.05338

0.01178

0.698

Slope of the associated linear model, R2 indicating how much variation that
model explains, and a p-value of the probability that the slope of the linear
model equals zero are reported
*Significance at 0.05 level; **Significance at 0.01 level

CAMKMT (calmodulin-lysine N-methyltransferase) is
expressed across a wide range of tissues and plays a pivotal role in the methylation of calmodulin, which changes
across developmental stages and varies in a tissue specific manner [40]. Deletion of a genomic region including
CAMKMT in humans has been associated with micrognathia, dolichocephaly, and cleft palate, although the
specific loss of CAMKMT has been associated with intellectual disability and muscle fiber abnormalities instead
of these craniofacial phenotypes [41]. Since CAMKMT
regulates calmodulin (CaM) function, it is also important

to note that calmodulin has been linked to variation in
beak length in Darwin’s finches and chicks [42]. CAMKMT is critical to basic physiological function across
the body and has tentatively been associated with severe
craniofacial birth defects.
SIX2 (sine oculus-related homeobox 2) is known to
play a significant role in the skeletal development of
pharyngeal arch derivatives. SIX2 is upregulated in neural crest-derived cranial mesenchyme in mice at E8.5
[43] and E9.5 [44], becoming localized to mesenchymal
cells of nasal prominences, midline, and developing skull
vault, as well as olfactory epithelium by E11.5 [43, 45, 46].
Downregulation of SIX2 can lead to loss or reduction in
facial skeletal elements [47], reduced cranial base length,
and cleft palate [48]. Later in development, SIX2 loss has
been linked to increased rates of cartilage replacement by
bone during endochondral ossification of the presphenoid, leading to an abnormal cranial base morphology
[49]. SIX2 regulates the formation of bones from the first
pharyngeal arch, which includes both the maxilla and
zygomatic bones.
SIX3 (sine oculus-related homeobox 3) interacts with
BMP, WNT, and NODAL, is critical during eye development [50–52], and during anterior neural plate specification [53]. Although SIX3 is not expressed in the maxillary
arch or other craniofacial mesenchyme during embryonic
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Fig. 7 RT-PCR results. RNA expression levels from E11.5 maxillary processes of three inbred mouse genotypes, relative to C57 expression levels

development [44], genetic variation in Six3 can lead to
craniofacial dysmorphology of maxillofacial bones [54],
particularly in the facial midline. Mutations in SIX3 can
cause holoprosencephaly in humans, a condition associated with forebrain malformation, intellectual disability,
ophthalmological abnormalities, and craniofacial features
including cyclopia, nasal dysmorphology, and cleft lip/
palate [55]. A combination of forebrain loss and modified ectoderm/mesenchyme interactions may underlie
the associated craniofacial dysmorphology (e.g., [56]).
SIX3OS1 (Six3 opposite strand) is an antisense non-coding RNA that is independently coexpressed with SIX3 in
the forebrain and eye after E8.5 in mice [57]. SIX3OS1
likely acts as a transcriptional scaffold for SIX3 and modulates the ability of Six3 to regulate expression of target
genes in retinal cells [58]. SIX3 and SIX3OS1 may indirectly regulate facial bone development.
Although all four candidate genes have been previously
associated with craniofacial dysmorphology, Six2 is particularly tantalizing because it is a major player in facial
bone ossification and is associated with RNA expression
level differences between founder strain maxillary prominences. Assuming that variation in Six2 or one of its cisregulatory factors is responsible, we speculate about how
variation in SIX2 expression might modify development

to produce zygomatic arch variation in our DO mice and
across mammalian clades.
Developmental mechanisms

All bones that contribute to the mouse zygomatic arch
form from neural crest-derived mesenchyme [59, 60]
within the first pharyngeal arch [61–63]. The maxilla
and zygomatic bone derive from neural crest cells that
migrate from the posterior mesencephalic region, while
much of the squamous temporal neural crest mesenchyme probably originates in the first couple of rhombomeres [5, 64]. Our results indicate that a gene or
regulatory element within our candidate interval determines the location of the border between the maxilla and
zygomatic within the adult zygomatic arch. Because the
zygomatic bone is the last remaining dermally ossified
circumorbital bone in mammals [6, 65] and appears to be
the only dermatocranial element that does not develop
in proximity to chondrocranial elements [66], it may
ossify in response to a different signal than the maxilla.
Although Dlx genes and related factors are associated
with determining upper and lower jaw fates within the
first pharyngeal arch [67], what determines the individual
bone fate of mesenchymal cells within the maxillary portion of the first pharyngeal arch remains unknown.
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Heuzé and colleagues [68] recently suggested that the
zygomatic progenitor cells experience developmental
cues analogous to Dlx expression patterns that distinguish them from maxillary cell populations. It is possible that one of these cues is the spatiotemporal pattern
of Six2 expression. Supporting this perspective, loss of
SIX1 results in a partial transformation of the zygomatic
process of the maxilla into a mandible, possibly through
downstream effects on Dlx gene expression [69]. This
partial morphological transformation includes a significant increase in the length and volume of the zygomatic
process of the maxilla and a significant reduction of the
zygomatic bone or the fusion of zygomatic and maxillary portions of the zygomatic arch together [69]. As
two members of the same gene family that are expressed
within the developing pharyngeal arches, it is possible
that SIX1 and SIX2 regulate development through similar pathways and mechanisms.
If a mutation in SIX2 leads to a change in how regional
segmentation genes like the Dlx genes are expressed, it
is possible that the variation in the contribution of maxilla and zygomatic to the zygomatic arch (Fig. 8a) may be
based on a change in the location of a regulatory gene
expression border between their presumptive cell populations (Fig. 8b). Tissue boundary definition is critical
in many developmental contexts [70]. One well-documented craniofacial example of a gene regulatory border
prevents mesenchymal and osteogenic cells from crossing the presumptive coronal suture between neural crest
and mesodermally derived mesenchymal cells [70–72]
(although, see [73]). A change in the relative location of
a gene regulatory boundary may serve to define the final
location of the zygomaticomaxillary suture.
There are other ways that a mutation in SIX2 might
modify developmental processes to lead the measured
zygomatic arch length variation. The site of the zygomaticomaxillary suture may not be defined prior to osteogenesis but may simply occur wherever the growing bones
meet. Six2 expression has been associated with increased
mesenchymal cell proliferation in the developing head
and renal system [48, 49, 74]. Recent results indicate that
Six2 mRNA and protein levels are highest in palatal tissues during the period of initial palatal shelf outgrowth
and suggest that later spatiotemporal expression patterns are responsible for local increases in mesenchymal
cell proliferation [48]. It is possible that genetic variation under our candidate region leads to a change in the
timing, location, or level of mesenchymal precursor cell
populations.
A change in proliferation within either the maxillary or
zygomatic mesenchymal condensations may result in size
variation of that condensation and the resulting bones
(Fig. 8c). Within chicken eyes, it has been shown that
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Zygomatic Bone Zygomatic Process

a
b
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d
Fig. 8 Potential developmental mechanisms underlying zygomatic
arch variation. Schematic models of developmental mechanisms by
which an a adult phenotype of relative skeletal contribution to the
zygomatic arch might occur. Options include b external regulatory
definition of a presumptive suture, c differences in initial mesenchymal condensation size, and d differences in relative growth or
ossification rates between the two bone primordia

the largest and most widely spaced intramembranously
ossified scleral ossicles tend to be those with the earliest
forming mesenchymal condensation precursors. In addition, if one ossicle fails to form, the adjacent ossicles fill
in the extra space [75]. In another relevant example, a
Fuz ciliopathy mutation leads to the formation of a single
frontal bone pair at the expense of parietal bones in mice,
perhaps because an excess proliferation of precursor cells
leads to an unusually wide frontal bone mesenchymal
condensation [76]. It is possible that a similar change in
the proliferation rate within the maxillary or zygomatic
bone mesenchymal condensations may cause them to
become larger at the expense of the other. While Six2 is
a tantalizing candidate gene that may drive the negative
pleiotropy in zygomatic arch bone lengths among DO
mice, further work is required to confirm this.
Evolutionary implications

The jugal bone (homologous with zygomatic bone) is
first noted in the fossil record as one of the circumorbital
bones within the dermal skeleton of agnathans. Within
the presumed ancestral tetrapod, the jugal was a narrow
bone of the inferior orbital margin that articulated with
facial bones including the lacrimal, maxilla, and squamosal (reviewed by [65, 68]). The zygomatic bone of the
last common ancestor of mammals was likely a linear
bone connecting the maxilla and squamosal bones that
lacked a postorbital connection to the frontal bone. This
view is supported by the existence of similar morphologies in living monotremes, marsupials and many other
mammalian clades. Among mammals, zygomatic arches
vary in their width, breadth, height, length, degree and
direction of curvature, among other characteristics. A
complete postorbital border between frontal and zygomatic bones is noted in some clades (e.g., cervids, equids,
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primates), is sometimes represented by zygomatic and
frontal processes that do not touch (e.g., carnivorans,
lagomorphs), and completely absent in other mammals
(e.g., bats, insectivores, rodents) [77–79]. Arch thickness
and robusticity may vary in response to selective pressure based on mechanical loading requirements [80–83],
with robust arches found in beaver and rabbits, thinner
arches in mice and moles, and a practically complete loss
in shrews.
Although a wide range of morphologies occur across
mammals, our results specifically relate to variation in the
relative contribution of bones to zygomatic arch length
between the main bodies of the maxilla and squamosal
bones. The zygomatic process of the maxilla, the zygomatic bone, and the zygomatic process of the squamous
temporal typically contribute to form the zygomatic arch.
Because only a short squamous temporal portion exists
in laboratory mice, our analysis focused on the zygomatic
and maxillary bone contributions to overall arch length.
Mouse strain haplotype variation noted under a genomic
interval on mouse chromosome 17 (85.3–85.9 Mb) is
responsible for significant variation in the relative contribution of these bones to arch length.
Analogous genetic variation may underlie variation in
the relative contribution of zygomatic arch elements to
total arch length across mammalian species. This sort of
phenotypic variation is common across mammalian taxa.
For example, carnivorans including felids and canids typically have a very short zygomatic process of the maxilla,
an anteriorly placed zygomatic bone, and a relatively long
zygomatic process of the temporal [78, 84] (Fig. 9a). On
the other hand, rodents typically have a long zygomatic
process of the maxilla, a more posteriorly placed zygomatic bone, and a short zygomatic process of the temporal [78, 85] (Fig. 9b). We propose that the identified
pattern of negative pleiotropy contributes to this mammalian variation in relative bone length, but not that it
explains all variation in zygomatic arch length or shape.

a

Two clades that were commonly thought to lack a
zygomatic bone illustrate how an extreme imbalance
in two zygomatic arch elements might manifest. First,
moles (Talpidae) may represent the logical extreme of
the proposed mechanism. Although moles lack a separate zygomatic bone as adults [78, 86] (Fig. 9c), one of the
multiple small zygomatic arch ossification centers [77]
may represent the zygomatic bone [87] and fuse with the
zygomatic process of the maxilla quite early in development. The mole zygomatic arch is a complete arch, with
a minor zygomatic bone contribution, and a lack of zygomatic arch sutures. The fossil order of Multiturberculata
was long considered unique as mammals with a robust
zygomatic arch, but lacking a zygomatic bone. However,
careful work by Hopson and colleagues [88] indicated
the zygomatic bone is found medial to the maxillary and
temporal portions of the arch rather than in between.
If the modified expression of a factor like SIX2 leads to
the expansion of one arch bone at the expense of another,
a fusion of the arch bones together and/or a displacement of the smaller bone may occur. In fact, SIX1 null
mutant mice with the enlarged zygomatic process of the
maxilla also display either a smaller displaced zygomatic
bone or fusion of zygomatic and maxillary portions of the
developing arch [69]. It is temping to speculate that this
reduction and fusion of the zygomatic bone might serve
as a foundation for total zygomatic bone loss. In moles,
where the existence of a zygomaticomaxillary suture is
not functionally necessary, a complete loss of the zygomatic bone ossification center would result in the same
morphology as long as the growing temporal and maxillary bones expanded further to fill in the gap as occurs
among chick scleral ossicles [75]. However, in the case of
the Multiturberculata, the continued presence of the displaced zygomatic bone may serve to reinforce the zygomatic arch response to mechanical forces [88]. Regardless
of the responsible factor, similar changes in developmental processes [89] may underlie the variation in zygomatic

b

c

?
Felis silvestris catus

Rattus norvegicus

Talpa europaea

Fig. 9 Mammal zygomatic contributions. a snapshot of mammalian variation in the relative contributions of zygomatic arch bones, including a
feral domestic cat (Felis silvestris catus), b a wild caught common rat (Rattus norvegicus), and c a European mole (Talpa europae). Outlines based on
images found on DigiMorph (digimorph.org). Colored lines representing the relative length of the zygomatic process of the maxilla (red), the zygomatic bone (blue), and the zygomatic process of the squamous temporal (green) match the colors noted in Figs. 2 and 8
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arch bone contributions among our DO mice and variation that has arisen during mammalian evolution.

Conclusions
Investigating how genetic factors constrain the range of
possible skull variation is critical for identifying mechanisms of integration and developmental constraint. Out
of three cranial regions studied, we identified a genomic
region underlying negative pleiotropy within the zygomatic arch. Association mapping and subsequent RT-PCR
analysis identified candidate genes that might underlie
this pattern. Further study is required to determine how
the responsible genetic factor modifies developmental
processes to limit overall zygomatic arch length while
allowing for variation in the relative length of contributing
zygomatic bones. This pattern of negative pleiotropy may
have contributed to the evolution of mammalian zygomatic arch diversity. Identifying the particular developmental basis for this negative pleiotropy has implications
beyond the zygomatic arch, because changes in similar
instances of negative pleiotropy underlie significant evolutionary variation in the relative contribution of adjacent
bones to larger morphological features in other regions
like the cranial vault and upper jaw. These results provide
a significant toe-hold in unraveling an example of negative pleiotropy and developmental constraint, which is an
important step toward understanding the developmental
basis for evolutionary change in the skull.
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